Rank | Gene Set | Z-score |
---|---|---|
1 | behavioral response to ethanol (GO:0048149) | 9.83517811 |
2 | phenol-containing compound catabolic process (GO:0019336) | 8.33118945 |
3 | aggressive behavior (GO:0002118) | 8.23249525 |
4 | exogenous drug catabolic process (GO:0042738) | 8.05964471 |
5 | neurotransmitter biosynthetic process (GO:0042136) | 8.05105168 |
6 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 7.40158845 |
7 | succinate metabolic process (GO:0006105) | 6.60397742 |
8 | drug catabolic process (GO:0042737) | 6.35473477 |
9 | regulation of neurotransmitter uptake (GO:0051580) | 6.24868170 |
10 | synaptic transmission, dopaminergic (GO:0001963) | 6.16892103 |
11 | behavioral response to nicotine (GO:0035095) | 6.05417494 |
12 | neurotransmitter metabolic process (GO:0042133) | 5.84106709 |
13 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.71821099 |
14 | peptidyl-cysteine modification (GO:0018198) | 5.46562502 |
15 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 5.42563698 |
16 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 5.42563698 |
17 | neurotransmitter secretion (GO:0007269) | 5.22579742 |
18 | neurotransmitter catabolic process (GO:0042135) | 5.10115150 |
19 | sympathetic nervous system development (GO:0048485) | 5.05277113 |
20 | insulin secretion (GO:0030073) | 4.89925206 |
21 | arginine catabolic process (GO:0006527) | 4.89804622 |
22 | synaptic vesicle exocytosis (GO:0016079) | 4.83851617 |
23 | ATP hydrolysis coupled proton transport (GO:0015991) | 4.79252389 |
24 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 4.79252389 |
25 | negative regulation of neurotransmitter transport (GO:0051589) | 4.77602256 |
26 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.59215965 |
27 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 4.57194254 |
28 | endocrine pancreas development (GO:0031018) | 4.41709034 |
29 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.37407213 |
30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.35472688 |
31 | maternal behavior (GO:0042711) | 4.34383484 |
32 | positive regulation of action potential (GO:0045760) | 4.26612646 |
33 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.26552647 |
34 | protein-cofactor linkage (GO:0018065) | 4.25803772 |
35 | catecholamine transport (GO:0051937) | 4.25574227 |
36 | startle response (GO:0001964) | 4.25251630 |
37 | glandular epithelial cell differentiation (GO:0002067) | 4.21947395 |
38 | glycerophospholipid catabolic process (GO:0046475) | 4.18953142 |
39 | gamma-aminobutyric acid transport (GO:0015812) | 4.16566946 |
40 | dicarboxylic acid catabolic process (GO:0043649) | 4.16217081 |
41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.16182978 |
42 | glutamine family amino acid catabolic process (GO:0009065) | 4.16168039 |
43 | regulation of neurotransmitter levels (GO:0001505) | 4.12899725 |
44 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.11500253 |
45 | artery smooth muscle contraction (GO:0014824) | 4.10798982 |
46 | cellular response to ammonium ion (GO:0071242) | 4.08891229 |
47 | phagosome maturation (GO:0090382) | 4.05733262 |
48 | vascular smooth muscle contraction (GO:0014829) | 4.01434024 |
49 | transferrin transport (GO:0033572) | 3.99184007 |
50 | neurotransmitter transport (GO:0006836) | 3.98063589 |
51 | type B pancreatic cell development (GO:0003323) | 3.94924420 |
52 | tonic smooth muscle contraction (GO:0014820) | 3.93748678 |
53 | peptide hormone processing (GO:0016486) | 3.86629819 |
54 | peptide hormone secretion (GO:0030072) | 3.85773727 |
55 | positive regulation of neurotransmitter transport (GO:0051590) | 3.84678640 |
56 | negative regulation of receptor activity (GO:2000272) | 3.82828556 |
57 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 3.81968317 |
58 | cellular zinc ion homeostasis (GO:0006882) | 3.79961015 |
59 | response to cocaine (GO:0042220) | 3.79080996 |
60 | dopamine metabolic process (GO:0042417) | 3.76653257 |
61 | parental behavior (GO:0060746) | 3.76049254 |
62 | peptide secretion (GO:0002790) | 3.73995653 |
63 | regulation of neurotransmitter transport (GO:0051588) | 3.73696264 |
64 | trivalent inorganic cation transport (GO:0072512) | 3.73124816 |
65 | ferric iron transport (GO:0015682) | 3.73124816 |
66 | synaptic transmission, cholinergic (GO:0007271) | 3.72045493 |
67 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.67509276 |
68 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.64604859 |
69 | astrocyte differentiation (GO:0048708) | 3.64330336 |
70 | neuronal action potential propagation (GO:0019227) | 3.61082840 |
71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.60191454 |
72 | negative regulation of hormone metabolic process (GO:0032351) | 3.59952979 |
73 | presynaptic membrane assembly (GO:0097105) | 3.58826375 |
74 | serotonin metabolic process (GO:0042428) | 3.58190261 |
75 | norepinephrine metabolic process (GO:0042415) | 3.57361317 |
76 | inositol phosphate catabolic process (GO:0071545) | 3.55471733 |
77 | zinc ion homeostasis (GO:0055069) | 3.55028967 |
78 | nitric oxide mediated signal transduction (GO:0007263) | 3.54846730 |
79 | response to pheromone (GO:0019236) | 3.52145468 |
80 | positive regulation of amine transport (GO:0051954) | 3.50786403 |
81 | neuron-neuron synaptic transmission (GO:0007270) | 3.50116575 |
82 | catecholamine biosynthetic process (GO:0042423) | 3.49915959 |
83 | catechol-containing compound biosynthetic process (GO:0009713) | 3.49915959 |
84 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.49592846 |
85 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.48211202 |
86 | glutamate secretion (GO:0014047) | 3.47703489 |
87 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.45399149 |
88 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.45305618 |
89 | positive regulation of glycolytic process (GO:0045821) | 3.44849294 |
90 | calcium ion import (GO:0070509) | 3.43072219 |
91 | neuromuscular synaptic transmission (GO:0007274) | 3.41731686 |
92 | neuron cell-cell adhesion (GO:0007158) | 3.39616405 |
93 | kidney morphogenesis (GO:0060993) | 3.36703066 |
94 | oxygen transport (GO:0015671) | 3.34943507 |
95 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.32045144 |
96 | regulation of hexokinase activity (GO:1903299) | 3.30181792 |
97 | regulation of glucokinase activity (GO:0033131) | 3.30181792 |
98 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.30168002 |
99 | sequestering of metal ion (GO:0051238) | 3.30095949 |
100 | positive regulation of insulin secretion (GO:0032024) | 3.29905973 |
101 | signal peptide processing (GO:0006465) | 3.26966054 |
102 | lactate metabolic process (GO:0006089) | 3.26718134 |
103 | neuromuscular process controlling posture (GO:0050884) | 3.26440320 |
104 | response to pain (GO:0048265) | 3.26259383 |
105 | negative regulation of microtubule polymerization (GO:0031115) | 3.26120305 |
106 | detection of calcium ion (GO:0005513) | 3.25748596 |
107 | regulation of vesicle fusion (GO:0031338) | 3.22430864 |
108 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.22262176 |
109 | vocalization behavior (GO:0071625) | 3.14940556 |
110 | polyol catabolic process (GO:0046174) | 3.14448703 |
111 | regulation of guanylate cyclase activity (GO:0031282) | 3.13822367 |
112 | positive regulation of peptide hormone secretion (GO:0090277) | 3.13548178 |
113 | cell migration in hindbrain (GO:0021535) | 3.12069333 |
114 | adenosine metabolic process (GO:0046085) | 3.11607970 |
115 | cellular ketone body metabolic process (GO:0046950) | 3.10997574 |
116 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.07921236 |
117 | glandular epithelial cell development (GO:0002068) | 3.07435332 |
118 | peptide transport (GO:0015833) | 3.07077807 |
119 | positive regulation of peptide secretion (GO:0002793) | 3.04258669 |
120 | hormone secretion (GO:0046879) | 3.02612233 |
121 | proline transport (GO:0015824) | 3.01146739 |
122 | positive regulation of macroautophagy (GO:0016239) | 2.98999018 |
123 | epithelial cell fate commitment (GO:0072148) | 2.98191380 |
124 | zinc ion transmembrane transport (GO:0071577) | 2.96433663 |
125 | regulation of neurotransmitter secretion (GO:0046928) | 2.95699565 |
126 | primary amino compound metabolic process (GO:1901160) | 2.94219578 |
127 | regulation of energy homeostasis (GO:2000505) | 2.93609233 |
128 | response to amphetamine (GO:0001975) | 2.93336750 |
129 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93221800 |
130 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.92643108 |
131 | presynaptic membrane organization (GO:0097090) | 2.90908468 |
132 | regulation of synaptic vesicle transport (GO:1902803) | 2.90890750 |
133 | signal release (GO:0023061) | 2.90143862 |
134 | multi-organism behavior (GO:0051705) | 2.89714305 |
135 | positive regulation of vesicle fusion (GO:0031340) | 2.89671655 |
136 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.88045141 |
137 | regulation of insulin secretion (GO:0050796) | 2.87949123 |
138 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.85986319 |
139 | protein import into peroxisome matrix (GO:0016558) | 2.85941748 |
140 | synaptic vesicle maturation (GO:0016188) | 2.85855647 |
141 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.85094854 |
142 | regulation of action potential (GO:0098900) | 2.84218622 |
143 | activation of protein kinase A activity (GO:0034199) | 2.83949192 |
144 | hormone transport (GO:0009914) | 2.83820043 |
145 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.83305807 |
146 | protein polyglutamylation (GO:0018095) | 2.83104424 |
147 | ATP synthesis coupled proton transport (GO:0015986) | 2.80772722 |
148 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.80772722 |
149 | cardiac left ventricle morphogenesis (GO:0003214) | 2.80181959 |
150 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.80148441 |
151 | arginine metabolic process (GO:0006525) | 2.78943367 |
152 | mating behavior (GO:0007617) | 2.77455868 |
153 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.77184702 |
154 | * synaptic transmission (GO:0007268) | 2.76767051 |
155 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.76564672 |
156 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.76264242 |
157 | inositol phosphate dephosphorylation (GO:0046855) | 2.76264242 |
158 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.76066262 |
159 | regulation of synapse structural plasticity (GO:0051823) | 2.74220764 |
160 | ketone body metabolic process (GO:1902224) | 2.73832808 |
161 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.73620707 |
162 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.73366488 |
163 | response to lipoprotein particle (GO:0055094) | 2.72476838 |
164 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.71140018 |
165 | righting reflex (GO:0060013) | 2.69278894 |
166 | negative regulation of dendrite development (GO:2000171) | 2.68519239 |
167 | positive regulation of hormone secretion (GO:0046887) | 2.67925068 |
168 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.66589417 |
169 | regulation of peptide hormone secretion (GO:0090276) | 2.66006057 |
170 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.65923501 |
171 | postsynaptic membrane organization (GO:0001941) | 2.65793376 |
172 | amide transport (GO:0042886) | 2.65512568 |
173 | toxin transport (GO:1901998) | 2.63970663 |
174 | response to dietary excess (GO:0002021) | 2.63949213 |
175 | fatty acid homeostasis (GO:0055089) | 2.62925227 |
176 | synapse assembly (GO:0007416) | 2.62787226 |
177 | nucleoside diphosphate catabolic process (GO:0009134) | 2.61492458 |
178 | regulation of peptide secretion (GO:0002791) | 2.60288583 |
179 | dendritic spine morphogenesis (GO:0060997) | 2.59466992 |
180 | response to gravity (GO:0009629) | 2.59125801 |
181 | zinc ion transport (GO:0006829) | 2.58261218 |
182 | regulation of hormone secretion (GO:0046883) | 2.55694288 |
183 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.54583307 |
184 | photoreceptor cell differentiation (GO:0046530) | 2.54519864 |
185 | eye photoreceptor cell differentiation (GO:0001754) | 2.54519864 |
186 | ovulation from ovarian follicle (GO:0001542) | 2.54375443 |
187 | pancreas development (GO:0031016) | 2.54059043 |
188 | neurofilament cytoskeleton organization (GO:0060052) | 2.52845413 |
189 | regulation of microtubule-based movement (GO:0060632) | 2.52025825 |
190 | adaptation of signaling pathway (GO:0023058) | 2.50302561 |
191 | dentate gyrus development (GO:0021542) | 2.49764910 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.75759584 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.46175075 |
3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.47699922 |
4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.44038100 |
5 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.30397220 |
6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.26962286 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.21988174 |
8 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 3.03870119 |
9 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.01717309 |
10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.80423945 |
11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64669352 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.55247803 |
13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.51927388 |
14 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48910875 |
15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.45708349 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40384156 |
17 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.40326784 |
18 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.36443433 |
19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36327555 |
20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36019752 |
21 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34899110 |
22 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34899110 |
23 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33878513 |
24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.32662340 |
25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21510128 |
26 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.18530074 |
27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.17347780 |
28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98564437 |
29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.94543297 |
30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.93539786 |
31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.92233906 |
32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.91848731 |
33 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.89829163 |
34 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.87537167 |
35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87252280 |
36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.86638010 |
37 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.84179899 |
38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81753614 |
39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79497787 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77730645 |
41 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73585083 |
42 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.70036084 |
43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69140687 |
44 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.64228885 |
45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62892290 |
46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.62246308 |
47 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61719270 |
48 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.60099997 |
49 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.58402513 |
50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.58389238 |
51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.55081310 |
52 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.51624371 |
53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.49594583 |
54 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.49219029 |
55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47859541 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.46335464 |
57 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.46326514 |
58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41847911 |
59 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41468715 |
60 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40484476 |
61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.38053932 |
62 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37954560 |
63 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.35852924 |
64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35082878 |
65 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32435857 |
66 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28977545 |
67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28948910 |
68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28080766 |
69 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24483102 |
70 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.24169198 |
71 | VDR_22108803_ChIP-Seq_LS180_Human | 1.23699933 |
72 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.23113708 |
73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.22891715 |
74 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.22480023 |
75 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21625409 |
76 | * JUN_21703547_ChIP-Seq_K562_Human | 1.20031900 |
77 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.18404207 |
78 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.17531684 |
79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16934227 |
80 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.16832962 |
81 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16756264 |
82 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16005628 |
83 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15760715 |
84 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.15357965 |
85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.15329413 |
86 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.14059702 |
87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14008909 |
88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.13695529 |
89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13295609 |
90 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12575281 |
91 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.12286569 |
92 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.12071049 |
93 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11781691 |
94 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10893071 |
95 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08842162 |
96 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06673210 |
97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05242836 |
98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04770308 |
99 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04362345 |
100 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03556335 |
101 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.01946269 |
102 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01519959 |
103 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01344576 |
104 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00748976 |
105 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00748976 |
106 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00523662 |
107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.00121111 |
108 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.00035665 |
109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99422339 |
110 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98451672 |
111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98301951 |
112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.97620944 |
113 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.96778020 |
114 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95425491 |
115 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.93175921 |
116 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92653130 |
117 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92319426 |
118 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91571962 |
119 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.90894988 |
120 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89956814 |
121 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89304964 |
122 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88587202 |
123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88328424 |
124 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88177973 |
125 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86616404 |
126 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86446153 |
127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85784480 |
128 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85688226 |
129 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84842270 |
130 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.83190472 |
131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83056244 |
132 | AR_19668381_ChIP-Seq_PC3_Human | 0.82823475 |
133 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82672010 |
134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.81430993 |
135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81034109 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002822_catalepsy | 6.95870230 |
2 | MP0001529_abnormal_vocalization | 4.16959125 |
3 | MP0004858_abnormal_nervous_system | 3.88504338 |
4 | MP0003283_abnormal_digestive_organ | 3.78264505 |
5 | MP0003646_muscle_fatigue | 3.64792647 |
6 | MP0003011_delayed_dark_adaptation | 3.46671159 |
7 | MP0009745_abnormal_behavioral_response | 3.20127288 |
8 | MP0002638_abnormal_pupillary_reflex | 3.18620776 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.94281051 |
10 | MP0004859_abnormal_synaptic_plasticity | 2.92620097 |
11 | MP0005645_abnormal_hypothalamus_physiol | 2.84309611 |
12 | MP0001501_abnormal_sleep_pattern | 2.81615284 |
13 | MP0010386_abnormal_urinary_bladder | 2.78867761 |
14 | MP0001440_abnormal_grooming_behavior | 2.78772324 |
15 | MP0009046_muscle_twitch | 2.73056814 |
16 | * MP0002064_seizures | 2.68319082 |
17 | MP0006276_abnormal_autonomic_nervous | 2.56902318 |
18 | MP0002734_abnormal_mechanical_nocicepti | 2.47352070 |
19 | MP0002572_abnormal_emotion/affect_behav | 2.44014308 |
20 | MP0002272_abnormal_nervous_system | 2.42461253 |
21 | MP0001905_abnormal_dopamine_level | 2.35052438 |
22 | MP0008872_abnormal_physiological_respon | 2.33338727 |
23 | MP0001944_abnormal_pancreas_morphology | 2.32419540 |
24 | MP0009780_abnormal_chondrocyte_physiolo | 2.28402304 |
25 | MP0001970_abnormal_pain_threshold | 2.26835498 |
26 | MP0002733_abnormal_thermal_nociception | 2.21887243 |
27 | MP0002837_dystrophic_cardiac_calcinosis | 2.20533126 |
28 | MP0001968_abnormal_touch/_nociception | 2.15782184 |
29 | MP0003122_maternal_imprinting | 2.06326817 |
30 | MP0000569_abnormal_digit_pigmentation | 2.06234768 |
31 | MP0004270_analgesia | 2.04976549 |
32 | MP0005167_abnormal_blood-brain_barrier | 2.04605216 |
33 | MP0002063_abnormal_learning/memory/cond | 2.03374530 |
34 | MP0002693_abnormal_pancreas_physiology | 2.02272090 |
35 | MP0002736_abnormal_nociception_after | 1.99119491 |
36 | MP0004233_abnormal_muscle_weight | 1.94191250 |
37 | MP0002102_abnormal_ear_morphology | 1.94126211 |
38 | MP0004043_abnormal_pH_regulation | 1.89792000 |
39 | MP0003195_calcinosis | 1.87801578 |
40 | MP0004924_abnormal_behavior | 1.80553167 |
41 | MP0005386_behavior/neurological_phenoty | 1.80553167 |
42 | MP0010234_abnormal_vibrissa_follicle | 1.79912390 |
43 | MP0002735_abnormal_chemical_nociception | 1.78441579 |
44 | MP0002938_white_spotting | 1.76752077 |
45 | MP0000538_abnormal_urinary_bladder | 1.66719053 |
46 | MP0000462_abnormal_digestive_system | 1.64940697 |
47 | MP0003787_abnormal_imprinting | 1.57352511 |
48 | MP0005448_abnormal_energy_balance | 1.53900170 |
49 | MP0001986_abnormal_taste_sensitivity | 1.51864073 |
50 | MP0006072_abnormal_retinal_apoptosis | 1.49860927 |
51 | MP0005075_abnormal_melanosome_morpholog | 1.49216832 |
52 | MP0000516_abnormal_urinary_system | 1.47385458 |
53 | MP0005367_renal/urinary_system_phenotyp | 1.47385458 |
54 | MP0008961_abnormal_basal_metabolism | 1.46917503 |
55 | MP0005253_abnormal_eye_physiology | 1.45117934 |
56 | MP0004084_abnormal_cardiac_muscle | 1.45034037 |
57 | MP0000013_abnormal_adipose_tissue | 1.44235153 |
58 | MP0002078_abnormal_glucose_homeostasis | 1.40332287 |
59 | MP0003045_fibrosis | 1.37727054 |
60 | MP0002184_abnormal_innervation | 1.36263738 |
61 | MP0002254_reproductive_system_inflammat | 1.30387071 |
62 | MP0002557_abnormal_social/conspecific_i | 1.27732799 |
63 | MP0002067_abnormal_sensory_capabilities | 1.25371347 |
64 | MP0004036_abnormal_muscle_relaxation | 1.23381353 |
65 | MP0005220_abnormal_exocrine_pancreas | 1.23070033 |
66 | MP0004484_altered_response_of | 1.22926875 |
67 | MP0002751_abnormal_autonomic_nervous | 1.22607535 |
68 | MP0000639_abnormal_adrenal_gland | 1.22313845 |
69 | MP0003633_abnormal_nervous_system | 1.21622361 |
70 | MP0008775_abnormal_heart_ventricle | 1.18621366 |
71 | MP0008569_lethality_at_weaning | 1.18486561 |
72 | MP0008874_decreased_physiological_sensi | 1.18296365 |
73 | MP0005551_abnormal_eye_electrophysiolog | 1.18202024 |
74 | MP0004811_abnormal_neuron_physiology | 1.17779789 |
75 | MP0004883_abnormal_blood_vessel | 1.17444457 |
76 | MP0001188_hyperpigmentation | 1.16951431 |
77 | MP0002163_abnormal_gland_morphology | 1.16387270 |
78 | MP0000631_abnormal_neuroendocrine_gland | 1.14290468 |
79 | MP0005197_abnormal_uvea_morphology | 1.13958630 |
80 | MP0005423_abnormal_somatic_nervous | 1.11947071 |
81 | MP0006138_congestive_heart_failure | 1.09672767 |
82 | MP0002127_abnormal_cardiovascular_syste | 1.09555759 |
83 | MP0003880_abnormal_central_pattern | 1.09170649 |
84 | MP0001984_abnormal_olfaction | 1.09112608 |
85 | MP0005646_abnormal_pituitary_gland | 1.08504114 |
86 | MP0000613_abnormal_salivary_gland | 1.08314077 |
87 | MP0003631_nervous_system_phenotype | 1.06704652 |
88 | MP0001486_abnormal_startle_reflex | 1.06683027 |
89 | MP0002909_abnormal_adrenal_gland | 1.06565453 |
90 | MP0010329_abnormal_lipoprotein_level | 1.06517167 |
91 | MP0005535_abnormal_body_temperature | 1.04769148 |
92 | MP0002234_abnormal_pharynx_morphology | 1.04144100 |
93 | MP0000955_abnormal_spinal_cord | 1.03994546 |
94 | MP0004885_abnormal_endolymph | 1.03888427 |
95 | MP0002332_abnormal_exercise_endurance | 1.02233912 |
96 | MP0004142_abnormal_muscle_tone | 1.00311989 |
97 | MP0009379_abnormal_foot_pigmentation | 0.99371257 |
98 | MP0002229_neurodegeneration | 0.96387843 |
99 | MP0000751_myopathy | 0.96073547 |
100 | MP0003953_abnormal_hormone_level | 0.95922971 |
101 | MP0003121_genomic_imprinting | 0.94761416 |
102 | MP0002066_abnormal_motor_capabilities/c | 0.89623530 |
103 | MP0000003_abnormal_adipose_tissue | 0.88848185 |
104 | MP0002069_abnormal_eating/drinking_beha | 0.88415023 |
105 | MP0001664_abnormal_digestion | 0.88407853 |
106 | MP0008789_abnormal_olfactory_epithelium | 0.87484527 |
107 | MP0009840_abnormal_foam_cell | 0.86769791 |
108 | MP0004145_abnormal_muscle_electrophysio | 0.86099893 |
109 | MP0002295_abnormal_pulmonary_circulatio | 0.84846220 |
110 | MP0003329_amyloid_beta_deposits | 0.84327633 |
111 | MP0005636_abnormal_mineral_homeostasis | 0.83719927 |
112 | MP0001756_abnormal_urination | 0.81835363 |
113 | MP0001502_abnormal_circadian_rhythm | 0.81754244 |
114 | MP0005379_endocrine/exocrine_gland_phen | 0.81466309 |
115 | MP0002009_preneoplasia | 0.80967238 |
116 | MP0003123_paternal_imprinting | 0.80900059 |
117 | MP0000372_irregular_coat_pigmentation | 0.79731862 |
118 | MP0002882_abnormal_neuron_morphology | 0.76581025 |
119 | MP0001485_abnormal_pinna_reflex | 0.76114850 |
120 | MP0001177_atelectasis | 0.75110514 |
121 | MP0004133_heterotaxia | 0.75079154 |
122 | MP0004085_abnormal_heartbeat | 0.73670833 |
123 | MP0005085_abnormal_gallbladder_physiolo | 0.73434930 |
124 | MP0002090_abnormal_vision | 0.72973083 |
125 | MP0002876_abnormal_thyroid_physiology | 0.71003238 |
126 | MP0008877_abnormal_DNA_methylation | 0.68636604 |
127 | MP0000778_abnormal_nervous_system | 0.68391835 |
128 | MP0001270_distended_abdomen | 0.66347214 |
129 | MP0005394_taste/olfaction_phenotype | 0.65088579 |
130 | MP0005499_abnormal_olfactory_system | 0.65088579 |
131 | MP0003632_abnormal_nervous_system | 0.64523034 |
132 | MP0004215_abnormal_myocardial_fiber | 0.63792201 |
133 | MP0005408_hypopigmentation | 0.63240940 |
134 | MP0000467_abnormal_esophagus_morphology | 0.59721105 |
135 | MP0002277_abnormal_respiratory_mucosa | 0.57470838 |
136 | MP0002152_abnormal_brain_morphology | 0.54960238 |
137 | MP0003718_maternal_effect | 0.54349997 |
138 | MP0001943_abnormal_respiration | 0.50973710 |
139 | MP0005171_absent_coat_pigmentation | 0.47589217 |
140 | MP0001764_abnormal_homeostasis | 0.46440760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypothermia (HP:0002045) | 9.73613482 |
2 | Focal motor seizures (HP:0011153) | 6.57952652 |
3 | Myokymia (HP:0002411) | 5.76024855 |
4 | Orthostatic hypotension (HP:0001278) | 5.51876083 |
5 | Hypoglycemic seizures (HP:0002173) | 5.43372499 |
6 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.89745045 |
7 | Atonic seizures (HP:0010819) | 4.84172442 |
8 | Abnormal autonomic nervous system physiology (HP:0012332) | 4.78505617 |
9 | Abnormal hair whorl (HP:0010721) | 4.69392214 |
10 | Hyperglycemia (HP:0003074) | 4.63208260 |
11 | Ketoacidosis (HP:0001993) | 4.50554745 |
12 | Neonatal hypoglycemia (HP:0001998) | 4.35529887 |
13 | Focal seizures (HP:0007359) | 4.34256682 |
14 | Oligomenorrhea (HP:0000876) | 4.26485657 |
15 | Hypoglycemic coma (HP:0001325) | 4.20863411 |
16 | Polyphagia (HP:0002591) | 4.19771809 |
17 | Abnormality of the pancreatic islet cells (HP:0006476) | 4.10938610 |
18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 4.10938610 |
19 | Limb dystonia (HP:0002451) | 3.90885382 |
20 | Febrile seizures (HP:0002373) | 3.85514475 |
21 | Generalized tonic-clonic seizures (HP:0002069) | 3.65835048 |
22 | Acute necrotizing encephalopathy (HP:0006965) | 3.61431387 |
23 | Spastic diplegia (HP:0001264) | 3.61034351 |
24 | Absence seizures (HP:0002121) | 3.54472062 |
25 | Pheochromocytoma (HP:0002666) | 3.53840793 |
26 | Neuroendocrine neoplasm (HP:0100634) | 3.52583819 |
27 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.47659029 |
28 | Abnormality of the labia minora (HP:0012880) | 3.47357524 |
29 | Visual hallucinations (HP:0002367) | 3.44453676 |
30 | Failure to thrive in infancy (HP:0001531) | 3.37783437 |
31 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37110406 |
32 | Amblyopia (HP:0000646) | 3.35864483 |
33 | Poor suck (HP:0002033) | 3.32149527 |
34 | Hemiparesis (HP:0001269) | 3.30529065 |
35 | Exotropia (HP:0000577) | 3.26199013 |
36 | Progressive cerebellar ataxia (HP:0002073) | 3.22553062 |
37 | Symptomatic seizures (HP:0011145) | 3.20798932 |
38 | Hyperventilation (HP:0002883) | 3.20186018 |
39 | Epileptic encephalopathy (HP:0200134) | 3.18465678 |
40 | Progressive macrocephaly (HP:0004481) | 3.18126355 |
41 | Hypoventilation (HP:0002791) | 3.13087406 |
42 | Dialeptic seizures (HP:0011146) | 3.07604165 |
43 | Large for gestational age (HP:0001520) | 3.07554883 |
44 | Autoamputation (HP:0001218) | 3.05842119 |
45 | Mitochondrial inheritance (HP:0001427) | 3.02676046 |
46 | Intestinal atresia (HP:0011100) | 2.97124096 |
47 | Abnormal eating behavior (HP:0100738) | 2.96643360 |
48 | Impaired pain sensation (HP:0007328) | 2.95386681 |
49 | Abnormality of pain sensation (HP:0010832) | 2.95386681 |
50 | Ketosis (HP:0001946) | 2.87895752 |
51 | Acute encephalopathy (HP:0006846) | 2.79377742 |
52 | Patchy hypopigmentation of hair (HP:0011365) | 2.77097368 |
53 | Enlarged penis (HP:0000040) | 2.75244757 |
54 | Narrow nasal bridge (HP:0000446) | 2.73687712 |
55 | Late onset (HP:0003584) | 2.70065504 |
56 | Epileptiform EEG discharges (HP:0011182) | 2.63264899 |
57 | White forelock (HP:0002211) | 2.61726999 |
58 | Abnormal pancreas size (HP:0012094) | 2.59008433 |
59 | Hepatoblastoma (HP:0002884) | 2.56757478 |
60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.56158153 |
61 | Myotonia (HP:0002486) | 2.48875586 |
62 | Increased CSF lactate (HP:0002490) | 2.45927877 |
63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44994645 |
64 | Poor eye contact (HP:0000817) | 2.44441066 |
65 | Anxiety (HP:0000739) | 2.43740991 |
66 | Hypsarrhythmia (HP:0002521) | 2.41663297 |
67 | Spastic tetraplegia (HP:0002510) | 2.40686791 |
68 | Hypomagnesemia (HP:0002917) | 2.39962749 |
69 | Increased circulating renin level (HP:0000848) | 2.38628933 |
70 | Abnormal sex determination (HP:0012244) | 2.33674861 |
71 | Sex reversal (HP:0012245) | 2.33674861 |
72 | Proximal tubulopathy (HP:0000114) | 2.33389264 |
73 | Heterochromia iridis (HP:0001100) | 2.33227601 |
74 | Hyperthyroidism (HP:0000836) | 2.30142153 |
75 | Agitation (HP:0000713) | 2.29467841 |
76 | Hypotension (HP:0002615) | 2.27651351 |
77 | Calf muscle hypertrophy (HP:0008981) | 2.26933606 |
78 | Cerebral edema (HP:0002181) | 2.26443752 |
79 | Resting tremor (HP:0002322) | 2.26436994 |
80 | Neoplasm of the adrenal cortex (HP:0100641) | 2.24778875 |
81 | Type II lissencephaly (HP:0007260) | 2.24068966 |
82 | Hepatocellular necrosis (HP:0001404) | 2.23545836 |
83 | Disproportionate short-trunk short stature (HP:0003521) | 2.23114442 |
84 | Abnormal pupillary function (HP:0007686) | 2.23030467 |
85 | Restlessness (HP:0000711) | 2.18617284 |
86 | Esotropia (HP:0000565) | 2.17252502 |
87 | Cholecystitis (HP:0001082) | 2.16619095 |
88 | Abnormal gallbladder physiology (HP:0012438) | 2.16619095 |
89 | Abnormality of the metopic suture (HP:0005556) | 2.16152158 |
90 | Specific learning disability (HP:0001328) | 2.13210976 |
91 | Nephrogenic diabetes insipidus (HP:0009806) | 2.13179048 |
92 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.12733022 |
93 | Psychosis (HP:0000709) | 2.11667559 |
94 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.11497512 |
95 | Hypoplasia of the brainstem (HP:0002365) | 2.11497512 |
96 | Abnormal drinking behavior (HP:0030082) | 2.10389720 |
97 | Polydipsia (HP:0001959) | 2.10389720 |
98 | Hypokinesia (HP:0002375) | 2.07905655 |
99 | Nasal speech (HP:0001611) | 2.07873856 |
100 | Dysdiadochokinesis (HP:0002075) | 2.07431338 |
101 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.07095804 |
102 | Generalized myoclonic seizures (HP:0002123) | 2.06207981 |
103 | Tongue fasciculations (HP:0001308) | 2.06150775 |
104 | Termporal pattern (HP:0011008) | 2.04888826 |
105 | Insidious onset (HP:0003587) | 2.04888826 |
106 | Testicular neoplasm (HP:0010788) | 2.04655989 |
107 | Truncal ataxia (HP:0002078) | 2.04647422 |
108 | Loss of speech (HP:0002371) | 2.04360430 |
109 | Prominent metopic ridge (HP:0005487) | 2.04023203 |
110 | Abnormality of vitamin B metabolism (HP:0004340) | 2.04002202 |
111 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03158536 |
112 | Malnutrition (HP:0004395) | 2.02464369 |
113 | Gait imbalance (HP:0002141) | 2.02154717 |
114 | Abnormal social behavior (HP:0012433) | 2.01364279 |
115 | Impaired social interactions (HP:0000735) | 2.01364279 |
116 | Optic disc pallor (HP:0000543) | 2.00596199 |
117 | Abnormality of the corticospinal tract (HP:0002492) | 1.99897201 |
118 | Abnormality of glycolysis (HP:0004366) | 1.98839993 |
119 | Increased serum pyruvate (HP:0003542) | 1.98839993 |
120 | Depression (HP:0000716) | 1.98462890 |
121 | Leukodystrophy (HP:0002415) | 1.97509465 |
122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91577235 |
123 | Abnormality of the vocal cords (HP:0008777) | 1.90935185 |
124 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90242485 |
125 | Fetal akinesia sequence (HP:0001989) | 1.88071684 |
126 | Muscular hypotonia of the trunk (HP:0008936) | 1.88009387 |
127 | Increased CSF protein (HP:0002922) | 1.87548506 |
128 | Generalized hypotonia (HP:0001290) | 1.87176095 |
129 | Sensory axonal neuropathy (HP:0003390) | 1.84424608 |
130 | Postural tremor (HP:0002174) | 1.84224103 |
131 | Impaired vibratory sensation (HP:0002495) | 1.83630007 |
132 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82333830 |
133 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82333830 |
134 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82333830 |
135 | Absent speech (HP:0001344) | 1.82197119 |
136 | Emotional lability (HP:0000712) | 1.82081595 |
137 | Sleep apnea (HP:0010535) | 1.81414172 |
138 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.81373262 |
139 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.81373262 |
140 | Esophageal neoplasm (HP:0100751) | 1.81093671 |
141 | Neoplasm of head and neck (HP:0012288) | 1.81093671 |
142 | Progressive inability to walk (HP:0002505) | 1.79936890 |
143 | Cerebellar dysplasia (HP:0007033) | 1.79195160 |
144 | Diminished movement (HP:0002374) | 1.79115316 |
145 | Dysmetria (HP:0001310) | 1.78437869 |
146 | X-linked dominant inheritance (HP:0001423) | 1.77024163 |
147 | Congenital primary aphakia (HP:0007707) | 1.76973447 |
148 | Barrel-shaped chest (HP:0001552) | 1.76690956 |
149 | Macroorchidism (HP:0000053) | 1.76517353 |
150 | Abnormality of magnesium homeostasis (HP:0004921) | 1.75751503 |
151 | Gaze-evoked nystagmus (HP:0000640) | 1.74608380 |
152 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73111059 |
153 | Mucopolysacchariduria (HP:0008155) | 1.73111059 |
154 | Hyperphosphatemia (HP:0002905) | 1.73085936 |
155 | Type I diabetes mellitus (HP:0100651) | 1.71981987 |
156 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.71843208 |
157 | Respiratory failure (HP:0002878) | 1.70954600 |
158 | Syncope (HP:0001279) | 1.70844043 |
159 | Progressive microcephaly (HP:0000253) | 1.70640773 |
160 | Cortical visual impairment (HP:0100704) | 1.70451594 |
161 | Status epilepticus (HP:0002133) | 1.70111382 |
162 | Ankle clonus (HP:0011448) | 1.69511256 |
163 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.69350665 |
164 | Menstrual irregularities (HP:0000858) | 1.69011396 |
165 | Tachypnea (HP:0002789) | 1.68883598 |
166 | True hermaphroditism (HP:0010459) | 1.68861795 |
167 | Medial flaring of the eyebrow (HP:0010747) | 1.67790181 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 6.70480151 |
2 | GRK7 | 5.79090218 |
3 | MAP3K12 | 4.73790963 |
4 | MAP3K4 | 4.57355646 |
5 | MAP2K7 | 4.20758871 |
6 | TRIM28 | 3.61835594 |
7 | NTRK1 | 3.56108516 |
8 | MAP2K4 | 2.74590828 |
9 | ARAF | 2.64812777 |
10 | FGFR2 | 2.54075106 |
11 | CASK | 2.38067687 |
12 | PASK | 2.37410342 |
13 | GRK5 | 2.35995699 |
14 | MAP4K2 | 2.23533195 |
15 | MATK | 2.17356428 |
16 | NTRK3 | 2.10309506 |
17 | PAK3 | 2.07443267 |
18 | NTRK2 | 1.94607470 |
19 | PNCK | 1.92448072 |
20 | MAP3K9 | 1.79418888 |
21 | PRKD3 | 1.78845135 |
22 | CAMK1D | 1.78614838 |
23 | ACVR1B | 1.78258423 |
24 | NME1 | 1.72658329 |
25 | DAPK1 | 1.72063095 |
26 | TSSK6 | 1.70252962 |
27 | MAP2K6 | 1.68105894 |
28 | MYLK | 1.67159855 |
29 | NLK | 1.66681971 |
30 | CAMK1G | 1.66553507 |
31 | MINK1 | 1.55580637 |
32 | AKT3 | 1.54107195 |
33 | MUSK | 1.52257096 |
34 | PRKCE | 1.47290611 |
35 | ERBB3 | 1.46161738 |
36 | MAP2K1 | 1.43921259 |
37 | ADRBK1 | 1.40445523 |
38 | DAPK2 | 1.38359563 |
39 | KSR2 | 1.24924405 |
40 | PLK2 | 1.24276774 |
41 | CAMK1 | 1.23904787 |
42 | CAMK4 | 1.23012410 |
43 | MKNK2 | 1.21237370 |
44 | RPS6KC1 | 1.20003776 |
45 | RPS6KL1 | 1.20003776 |
46 | UHMK1 | 1.18746448 |
47 | PINK1 | 1.18700331 |
48 | MARK1 | 1.14502373 |
49 | CSNK1G2 | 1.11495021 |
50 | PDK4 | 1.09307598 |
51 | PDK3 | 1.09307598 |
52 | PRKCG | 1.06776768 |
53 | CSNK1G3 | 1.04732762 |
54 | HIPK2 | 1.03691864 |
55 | STK39 | 1.01734610 |
56 | STK3 | 0.99943858 |
57 | LIMK1 | 0.99694147 |
58 | SGK3 | 0.99517192 |
59 | PRKD2 | 0.98957668 |
60 | TAOK1 | 0.98707304 |
61 | CAMK2A | 0.97973018 |
62 | RPS6KA6 | 0.97675693 |
63 | EIF2AK3 | 0.97517935 |
64 | CDK5 | 0.93691738 |
65 | BRAF | 0.91801550 |
66 | SGK494 | 0.91253235 |
67 | SGK223 | 0.91253235 |
68 | CAMK2B | 0.89984037 |
69 | STK38L | 0.86253492 |
70 | CSNK1A1L | 0.85433479 |
71 | MAP3K2 | 0.82969565 |
72 | MST4 | 0.81592544 |
73 | DYRK3 | 0.80638075 |
74 | FGFR3 | 0.79106425 |
75 | MAPK13 | 0.78609996 |
76 | GRK1 | 0.76485981 |
77 | YES1 | 0.76200883 |
78 | DAPK3 | 0.75612200 |
79 | MAPKAPK5 | 0.73688258 |
80 | RPS6KA2 | 0.71919921 |
81 | SIK2 | 0.70765992 |
82 | FES | 0.70751110 |
83 | STK24 | 0.70316956 |
84 | INSRR | 0.70182074 |
85 | CDK3 | 0.68399875 |
86 | ERBB4 | 0.68051724 |
87 | DMPK | 0.67255825 |
88 | SIK3 | 0.63909680 |
89 | EPHA3 | 0.63587453 |
90 | CDK19 | 0.63137922 |
91 | SGK1 | 0.62813118 |
92 | STK11 | 0.61577755 |
93 | BMPR1B | 0.61466591 |
94 | CAMK2G | 0.61331391 |
95 | CDK14 | 0.60846852 |
96 | CAMKK2 | 0.60301639 |
97 | BRD4 | 0.60060652 |
98 | DYRK1A | 0.59747807 |
99 | CDK18 | 0.59584879 |
100 | CAMK2D | 0.59294122 |
101 | CSNK1A1 | 0.58167497 |
102 | CDK15 | 0.57951897 |
103 | GRK6 | 0.57567707 |
104 | CSNK1G1 | 0.56130384 |
105 | NEK1 | 0.54223960 |
106 | PDK2 | 0.52833257 |
107 | PRKCI | 0.52728219 |
108 | PRKAA1 | 0.52270706 |
109 | SGK2 | 0.51461253 |
110 | NUAK1 | 0.51190140 |
111 | OXSR1 | 0.48900336 |
112 | RPS6KA5 | 0.48879977 |
113 | MAP3K1 | 0.48604057 |
114 | PHKG1 | 0.48424346 |
115 | PHKG2 | 0.48424346 |
116 | GSK3A | 0.47039510 |
117 | CDK11A | 0.46799623 |
118 | CSNK1D | 0.46640772 |
119 | CDC42BPA | 0.46366126 |
120 | PRKCZ | 0.44487337 |
121 | PRKACA | 0.44038752 |
122 | MAP3K13 | 0.43135403 |
123 | ALK | 0.42801770 |
124 | RAF1 | 0.42163690 |
125 | PRKAA2 | 0.41340760 |
126 | ROCK1 | 0.41108928 |
127 | MAP3K6 | 0.40574301 |
128 | WNK1 | 0.40505563 |
129 | EPHA4 | 0.39204602 |
130 | FER | 0.39203318 |
131 | PIM2 | 0.39062392 |
132 | BUB1 | 0.38490379 |
133 | PTK2B | 0.36970218 |
134 | PRKDC | 0.36639192 |
135 | CCNB1 | 0.35823598 |
136 | TESK1 | 0.33888623 |
137 | ROCK2 | 0.33857462 |
138 | LMTK2 | 0.32687348 |
139 | PAK6 | 0.32374174 |
140 | PRKCH | 0.31906283 |
141 | PRKACG | 0.31450646 |
142 | ADRBK2 | 0.30796516 |
143 | CAMKK1 | 0.30611857 |
144 | CSNK1E | 0.30000864 |
145 | WNK4 | 0.29023572 |
146 | MOS | 0.26992581 |
147 | LATS2 | 0.26508099 |
148 | WNK3 | 0.26423289 |
149 | PRKCB | 0.24781617 |
150 | SYK | 0.21243057 |
151 | PRKCA | 0.20551367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 6.87561114 |
2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 4.79063251 |
3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.69706127 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.61053367 |
5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.99376382 |
6 | Protein export_Homo sapiens_hsa03060 | 2.88665460 |
7 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.67218173 |
8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.51604769 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.43660500 |
10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.41707173 |
11 | GABAergic synapse_Homo sapiens_hsa04727 | 2.41665977 |
12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.16568890 |
13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.02517399 |
14 | Long-term depression_Homo sapiens_hsa04730 | 1.97444094 |
15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.97190706 |
16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.91346742 |
17 | Circadian entrainment_Homo sapiens_hsa04713 | 1.88361124 |
18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.85909212 |
19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.84278306 |
20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.82008518 |
21 | Taste transduction_Homo sapiens_hsa04742 | 1.81394865 |
22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.81001022 |
23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.79723143 |
24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77925982 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.76416639 |
26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.74262579 |
27 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.70212590 |
28 | Olfactory transduction_Homo sapiens_hsa04740 | 1.69301582 |
29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.68646970 |
30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.67437696 |
31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.65883706 |
32 | Salivary secretion_Homo sapiens_hsa04970 | 1.65810477 |
33 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.64788906 |
34 | Morphine addiction_Homo sapiens_hsa05032 | 1.61882643 |
35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.58459108 |
36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.50743711 |
37 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.46029479 |
38 | Renin secretion_Homo sapiens_hsa04924 | 1.44884954 |
39 | Long-term potentiation_Homo sapiens_hsa04720 | 1.43079963 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39917838 |
41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.39531995 |
42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.36041965 |
43 | Phagosome_Homo sapiens_hsa04145 | 1.33847130 |
44 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.33374583 |
45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32721139 |
46 | Peroxisome_Homo sapiens_hsa04146 | 1.29593601 |
47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.28079431 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.26251862 |
49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22593429 |
50 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20494294 |
51 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19602132 |
52 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.19418116 |
53 | Insulin secretion_Homo sapiens_hsa04911 | 1.19238358 |
54 | Gap junction_Homo sapiens_hsa04540 | 1.14182278 |
55 | Proteasome_Homo sapiens_hsa03050 | 1.12988366 |
56 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11428158 |
57 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05804939 |
58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04553829 |
59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.99305156 |
60 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.99271957 |
61 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.98129379 |
62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.94050092 |
63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92562447 |
64 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92277133 |
65 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.90179015 |
66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88404938 |
67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.87172155 |
68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.86216329 |
69 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.83888414 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.83107586 |
71 | ABC transporters_Homo sapiens_hsa02010 | 0.83083148 |
72 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.82992932 |
73 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79211628 |
74 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78606319 |
75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78355364 |
76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76786154 |
77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67445967 |
78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66615892 |
79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.61933001 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.60960947 |
81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.60667764 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60547813 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59644827 |
84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59533588 |
85 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.58665047 |
86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55692980 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55107734 |
88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.54384365 |
89 | Lysosome_Homo sapiens_hsa04142 | 0.53796366 |
90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53440880 |
91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52774459 |
92 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50369930 |
93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50361516 |
94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50319659 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49191369 |
96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48878666 |
97 | Bile secretion_Homo sapiens_hsa04976 | 0.47998267 |
98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.45349554 |
99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.45307311 |
100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43387058 |
101 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43136130 |
102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.40090126 |
103 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39952499 |
104 | Melanogenesis_Homo sapiens_hsa04916 | 0.38992939 |
105 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.38664533 |
106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.38111400 |
107 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38077541 |
108 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35986879 |
109 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34721787 |
110 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34495726 |
111 | * Alcoholism_Homo sapiens_hsa05034 | 0.34067383 |
112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.33753870 |
113 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33139285 |
114 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32960560 |
115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.32285468 |
116 | Tight junction_Homo sapiens_hsa04530 | 0.31932723 |
117 | Prion diseases_Homo sapiens_hsa05020 | 0.30272662 |
118 | Axon guidance_Homo sapiens_hsa04360 | 0.26496592 |
119 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24116218 |
120 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.24048283 |
121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.23124606 |
122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.20525595 |
123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.19754551 |
124 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19453272 |
125 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.19307418 |
126 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18078366 |
127 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17929963 |
128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13212950 |
129 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12686760 |
130 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.12660994 |
131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.10253447 |
132 | Phototransduction_Homo sapiens_hsa04744 | 0.09773245 |
133 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.09389675 |
134 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.09361319 |
135 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.09336538 |
136 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.08310584 |
137 | Glioma_Homo sapiens_hsa05214 | 0.05831807 |